Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China

Objective. This study was designed to compare the effects of metformin and repaglinide on the fasting plasma glucose (FPG) and glycated haemoglobin (HbA1c) in newly diagnosed type 2 diabetes in China. Methods. A total of 107 newly diagnosed type 2 diabetic patients (46 women and 61 men) participated...

Full description

Saved in:

Bibliographic Details
Main Authors:	J. Ma, L. Y. Liu, P. H. Wu, Y. Liao, T. Tao, W. Liu
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2014/294017
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
by: Yu-Ling Lin, et al.
Published: (2025-01-01)

Upregulation of FOXO3 in New-Onset Type 1 Diabetes Mellitus
by: Magdalena Zurawek, et al.
Published: (2020-01-01)

Effects Of Metformin And Myo-Inositol In Combination Versus Metformin As Monotherapy On The Metabolic Profile Of Polycystic Ovarian Syndrome Patients With Infertility
by: Hira Ehsan Khattak, et al.
Published: (2024-09-01)

Metformin versus insulin in gestational diabetes mellitus: a systematic review
by: Giovanna Noronha Berti, et al.
Published: (2025-01-01)

Exploring Inflammatory Changes in the Peripheral Blood of Type 2 Diabetes Mellitus in China
by: Li D, et al.
Published: (2025-02-01)

Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study
by: Yoshiro Fushimi, et al.
Published: (2020-01-01)

Prolonged Honeymoon Phase in Adult-Onset Type 1 Diabetes Mellitus: A Case Study
by: Pranjali Shah
Published: (2024-04-01)

Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
by: Yaodu Wang, et al.
Published: (2017-01-01)

Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
by: Nixiao Zhang, et al.
Published: (2018-01-01)

Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy
by: Christine A Hughes, et al.
Published: (2005-01-01)

Downregulation of Type II Diabetes Mellitus and Maturity Onset Diabetes of Young Pathways in Human Pancreatic Islets from Hyperglycemic Donors
by: Jalal Taneera, et al.
Published: (2014-01-01)

Does Diabetes Mellitus Alter the Onset and Clinical Course of Vascular Dementia?
by: Santosh B. Murthy, et al.
Published: (2010-01-01)

Comparison of Prevalence of Pre-Diabetes and Type-2 Diabetes Mellitus Between Athletes and Non-Athletes
by: Muhammad Irfan, et al.
Published: (2025-01-01)

Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer
by: Amit D. Raval, et al.
Published: (2016-01-01)

Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
by: Massimiliano Veroux, et al.
Published: (2013-01-01)

The onset of Type 3C diabetes mellitus in a young female due to distal pancreatectomy for solid pseudopapillary neoplasm
by: Ayaka Harada, et al.
Published: (2025-02-01)

The Prevalence and Causes of Visual Impairment in Type 2 Diabetes Mellitus in Northeast China
by: Liang Wen, et al.
Published: (2020-01-01)

The Comparison and Correlation of Serum Levels of Insulin and Na+/ K+ Atpase In Type 2 Diabetes Mellitus (T2DM) And Non-Diabetes Mellitus Individuals
by: Karar Kazem Mohammed, et al.
Published: (2022-09-01)

Comparison of effectiveness of aspirin, clopidogrel and cilostazol monotherapy treatment in ischaemic stroke
by: Endarwati Tuti, et al.
Published: (2025-01-01)

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn’s Disease
by: Min Seob Kwak, et al.
Published: (2018-01-01)

The Dynamics of Type 2 Diabetes Mellitus Prevalence and Management Rates among Rural Population in Henan Province, China
by: Xiaotian Liu, et al.
Published: (2017-01-01)

Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey
by: Jing Liu, et al.
Published: (2023-04-01)

Integrated Approach for Biomarker Discovery and Mechanistic Insights into the Co-Pathogenesis of Type 2 Diabetes Mellitus and Non-Hodgkin Lymphoma
by: Zhu Y, et al.
Published: (2025-01-01)

Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
by: Sang Ouk Chin, et al.
Published: (2020-01-01)

Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial
by: Daizhi Yang, et al.
Published: (2020-01-01)

Evaluation of Therapeutic Benefits of a Novel Herbal Ingredient-Based Hyaluronic Acid Gel as Monotherapy for Inflammatory Enlargement of a Patient with Diabetes Mellitus
by: Jaahnavi Lanka, et al.
Published: (2022-01-01)

Comparison of glimepiride and linagliptin in the treatment of non-alcoholic hepatic disease with type 2 diabetes mellitus
by: Feng Tian, et al.
Published: (2023-02-01)

Maturity-Onset Diabetes of Young Type 5: Diabetes with Extrapancreatic Features
by: Adnan Haider, et al.
Published: (2021-01-01)

SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study
by: Kunrong Wu, et al.
Published: (2020-01-01)

Survival Analysis of Diabetic Colorectal Cancer Patients on Metformin
by: Alex Brandon Wong, et al.
Published: (2023-12-01)

New Predictive Factors in the Development of Type 2 Diabetes Mellitus
by: Maurio González Hernández
Published: (2023-07-01)

Enhanced Apoptosis of Monocytes from Complication-Free Juvenile-Onset Diabetes Mellitus Type 1 May Be Ameliorated by TNF-α Inhibitors
by: Jolanta Myśliwska, et al.
Published: (2014-01-01)

Modulation of Adipocytokines Production and Serum NEFA Level by Metformin, Glimepiride, and Sitagliptin in HFD/STZ Diabetic Rats
by: Mohamed I. Saad, et al.
Published: (2015-01-01)

Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
by: Cao R, et al.
Published: (2025-02-01)

Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
by: Limin Zhai, et al.
Published: (2015-01-01)

Association of P2X7 polymorphisms on Type 2 diabetes mellitus susceptibility and diabetic complications.
by: Guoni Huang, et al.
Published: (2025-01-01)

Metformin Treatment in Type 2 Diabetes in Pregnancy: An Active Controlled, Parallel-Group, Randomized, Open Label Study in Patients with Type 2 Diabetes in Pregnancy
by: Jahan Ara Ainuddin, et al.
Published: (2015-01-01)

Type 2 Diabetes Mellitus, a Sequel of Untreated Childhood Onset Growth Hormone Deficiency Developing in a 17-Year-Old Patient
by: Rohan K. Henry, et al.
Published: (2018-01-01)

The Association of COPD Exacerbations with New Onset Type 2 Diabetes among Medicare Patients
by: Joseph S. Marino, et al.
Published: (2017-11-01)

Liver Damage in Type 1 Diabetes Mellitus
by: A. O. Bueverov, et al.
Published: (2021-06-01)